InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Cytosorbents Corp

CTSO Clue Score34
United States Fiscal year ends December CIK 0001175151
$3.79 +1.61% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.79 −45.15% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue9.5Operating income−11.5Net income−11.8Fiscal year 2017Revenue15.2 +59.0%Operating income−9.8Net income−8.5Fiscal year 2018Revenue22.5 +48.5%Operating income−15.6Net income−17.2Fiscal year 2019Revenue24.9 +10.9%Operating income−19.0Net income−19.3EPS, diluted−0.60Fiscal year 2020Revenue41.0 +64.4%Operating income−10.4Net income−7.8EPS, diluted−0.20Fiscal year 2021Revenue43.2 +5.3%Operating income−22.7Net income−24.6EPS, diluted−0.57Fiscal year 2022Revenue34.7 −19.6%Operating income−31.5Net income−32.8EPS, diluted−0.75Fiscal year 2023Revenue31.1 −10.4%Operating income−31.9Net income−29.2EPS, diluted−0.65Fiscal year 2024Revenue35.6 +14.5%Operating income−16.5Net income−20.7EPS, diluted−0.38Fiscal year 2025Revenue37.1 +4.1%Operating income−14.7Net income−8.2EPS, diluted−0.13
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 9.5 15.2 22.5 24.9 41.0 43.2 34.7 31.1 35.6 37.1
Growth +59.0% +48.5% +10.9% +64.4% +5.3% −19.6% −10.4% +14.5% +4.1%
Operating income −11.5 −9.8 −15.6 −19.0 −10.4 −22.7 −31.5 −31.9 −16.5 −14.7
Net income −11.8 −8.5 −17.2 −19.3 −7.8 −24.6 −32.8 −29.2 −20.7 −8.2
Growth
EPS, diluted n/a n/a n/a −0.60 −0.20 −0.57 −0.75 −0.65 −0.38 −0.13
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin58.5%Operating margin−120.6%Net margin−123.5%Free cash flow margin−72.1%Fiscal year 2017Gross margin63.6%Operating margin−65.0%Net margin−55.8%Free cash flow margin−49.2%Fiscal year 2018Gross margin66.7%Operating margin−69.3%Net margin−76.5%Free cash flow margin−51.2%Fiscal year 2019Gross margin70.5%Operating margin−76.0%Net margin−77.2%Free cash flow margin−70.0%Fiscal year 2020Gross margin73.0%Operating margin−25.3%Net margin−19.1%Free cash flow margin−15.4%Fiscal year 2021Gross margin74.4%Operating margin−52.7%Net margin−56.9%Free cash flow margin−40.9%Fiscal year 2022Gross margin59.8%Operating margin−90.9%Net margin−94.6%Free cash flow margin−98.9%Fiscal year 2023Gross margin70.6%Operating margin−102.8%Net margin−94.1%Free cash flow margin−71.4%Fiscal year 2024Gross margin69.9%Operating margin−46.2%Net margin−58.2%Free cash flow margin−41.3%Fiscal year 2025Gross margin71.5%Operating margin−39.8%Net margin−22.1%Free cash flow margin−33.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 58.5% 63.6% 66.7% 70.5% 73.0% 74.4% 59.8% 70.6% 69.9% 71.5%
Operating margin −120.6% −65.0% −69.3% −76.0% −25.3% −52.7% −90.9% −102.8% −46.2% −39.8%
Net margin −123.5% −55.8% −76.5% −77.2% −19.1% −56.9% −94.6% −94.1% −58.2% −22.1%
Free cash flow margin −72.1% −49.2% −51.2% −70.0% −15.4% −40.9% −98.9% −71.4% −41.3% −33.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−6.7Capital expenditure−0.1Free cash flow−6.9Fiscal year 2017Operating cash flow−6.5Capital expenditure−1.0Free cash flow−7.5Fiscal year 2018Operating cash flow−10.8Capital expenditure−0.7Free cash flow−11.5Fiscal year 2019Operating cash flow−16.8Capital expenditure−0.7Free cash flow−17.5Fiscal year 2020Operating cash flow−5.6Capital expenditure−0.7Free cash flow−6.3Fiscal year 2021Operating cash flow−14.0Capital expenditure−3.6Free cash flow−17.6Fiscal year 2022Operating cash flow−28.2Capital expenditure−6.1Free cash flow−34.3Fiscal year 2023Operating cash flow−21.7Capital expenditure−0.5Free cash flow−22.2Fiscal year 2024Operating cash flow−14.4Capital expenditure−0.3Free cash flow−14.7Fiscal year 2025Operating cash flow−12.4Capital expenditure−0.2Free cash flow−12.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.7 −6.5 −10.8 −16.8 −5.6 −14.0 −28.2 −21.7 −14.4 −12.4
Capital expenditure −0.1 −1.0 −0.7 −0.7 −0.7 −3.6 −6.1 −0.5 −0.3 −0.2
Free cash flow −6.9 −7.5 −11.5 −17.5 −6.3 −17.6 −34.3 −22.2 −14.7 −12.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash5.2Total debt4.9Net cash (debt)0.3Shareholders’ equity1.3Debt to equity3.67Fiscal year 2017Cash17.3Total debt10.0Net cash (debt)7.3Shareholders’ equity10.3Debt to equity0.97Fiscal year 2018Cash22.4Total debt9.9Net cash (debt)12.4Shareholders’ equity16.9Debt to equity0.59Fiscal year 2019Cash12.2Total debt15.1Net cash (debt)−2.8Shareholders’ equity3.4Debt to equity4.40Fiscal year 2020Cash71.4Total debt0.0Net cash (debt)71.4Shareholders’ equity79.2Debt to equity0.00Fiscal year 2021Cash52.1Shareholders’ equity62.6Fiscal year 2022Cash22.1Total debt5.0Net cash (debt)17.1Shareholders’ equity35.4Debt to equity0.14Fiscal year 2023Cash14.1Total debt5.0Net cash (debt)9.1Shareholders’ equity23.5Debt to equity0.21Fiscal year 2024Cash3.3Total debt14.0Net cash (debt)−10.7Shareholders’ equity11.1Debt to equity1.26Fiscal year 2025Cash6.2Total debt16.7Net cash (debt)−10.4Shareholders’ equity5.9Debt to equity2.82
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 5.2 17.3 22.4 12.2 71.4 52.1 22.1 14.1 3.3 6.2
Total debt 4.9 10.0 9.9 15.1 0.0 n/a 5.0 5.0 14.0 16.7
Net cash (debt) 0.3 7.3 12.4 −2.8 71.4 n/a 17.1 9.1 −10.7 −10.4
Shareholders’ equity 1.3 10.3 16.9 3.4 79.2 62.6 35.4 23.5 11.1 5.9
Debt to equity 3.67 0.97 0.59 4.40 0.00 n/a 0.14 0.21 1.26 2.82

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
9.5 15.2 22.5 24.9 41.0 43.2 34.7 31.1 35.6 37.1
Growth +59.0% +48.5% +10.9% +64.4% +5.3% −19.6% −10.4% +14.5% +4.1%
4.0 5.5 7.5 7.4 11.1 11.0 14.0 9.1 10.7 10.6
5.6 9.6 15.0 17.6 30.0 32.1 20.7 22.0 24.9 26.5
Growth +72.8% +55.9% +17.1% +70.3% +7.2% −35.4% +5.9% +13.4% +6.4%
4.1 3.2 7.7 12.1 8.8 16.4 15.1 15.7 n/a n/a
11.8 14.9 20.9 22.0 28.5 35.8 34.3 38.3 33.7 35.6
−11.5 −9.8 −15.6 −19.0 −10.4 −22.7 −31.5 −31.9 −16.5 −14.7
Growth
−12.1 −9.1 −17.8 −20.4 −9.0 −25.3 −33.9 −30.1 −22.4 −8.6
−0.3 −0.7 −0.6 −1.1 −1.1 −0.7 −1.1 −0.8 −1.7 −0.4
−11.8 −8.5 −17.2 −19.3 −7.8 −24.6 −32.8 −29.2 −20.7 −8.2
Growth
Per share
n/a n/a n/a −0.60 −0.20 −0.57 −0.75 −0.65 −0.38 −0.13
n/a n/a n/a −0.60 −0.20 −0.57 −0.75 −0.65 −0.38 −0.13
Growth
n/a n/a n/a 32.3 38.8 43.4 43.6 44.7 54.4 62.2
n/a n/a n/a 32.3 38.8 43.4 43.6 44.7 54.4 62.2
Growth +20.3% +11.7% +0.5% +2.5% +21.9% +14.3%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 2.0% a year over five years.
  • The diluted share count rose 60.3% in five years, which is dilution.
  • Operating margin is down 14.5 points on five years ago, at -39.8%.
  • A net loss in 10 of 10 years on file.